Major bleeding complications in patients treated with direct oral anticoagulants: One-year observational study in a

L Deville1, M Konan2, A Hij3

  • 1Service de pharmacie, hôpital Saint-Louis, Assistance publique-Hôpitaux de Paris, 1, avenue Claude-Vellefaux, 75010 Paris, France.

Insights

Direct oral anticoagulants (DOACs) offer benefits but can cause severe bleeding. Managing these bleeding complications is challenging due to the lack of specific antidotes, necessitating careful risk-benefit assessment.

Area of Science:

  • Pharmacology
  • Clinical Medicine
  • Hemorrhagic Complications

Background:

  • Direct oral anticoagulants (DOACs) are increasingly prescribed for venous thromboembolism and stroke prevention in atrial fibrillation.
  • DOACs offer advantages over vitamin K antagonists (VKAs) but pose bleeding risks.
  • Managing DOAC-associated bleeding is complex due to the absence of specific reversal agents.

Purpose of the Study:

  • To report and discuss major hemorrhagic complications associated with DOAC therapy.
  • To highlight the challenges in managing DOAC-induced bleeding.
  • To emphasize the importance of risk-benefit assessment before initiating DOACs.

Main Methods:

  • Retrospective case series analysis.
  • Pharmacological surveillance data from Saint-Louis University Hospital (Paris, France).
  • Review of five cases of major hemorrhagic complications over one year.

Main Results:

  • Five cases of major hemorrhagic complications under DOAC therapy were identified.
  • Treatment of these severe bleeding events presented significant clinical challenges.
  • The study underscores the complexity of managing DOAC-related hemorrhages.

Conclusions:

  • DOACs, despite their benefits, are associated with potentially severe bleeding.
  • Effective management strategies for DOAC-induced bleeding complications are crucial.
  • A thorough risk-benefit evaluation is essential for safe DOAC prescription.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...